SwePub
Sök i SwePub databas

  Extended search

Träfflista för sökning "WFRF:(Wiklund Olof) "

Search: WFRF:(Wiklund Olof)

  • Result 1-10 of 49
Sort/group result
   
EnumerationReferenceCoverFind
1.
  • Sundin, Olof, et al. (author)
  • Förord
  • 2012
  • In: En vänbok till Birgitta Olander: tankar och erfarenheter från f d studenter. - 9789163716058 ; BIVILs skriftserie 2012:1, s. 5-9
  • Book chapter (pop. science, debate, etc.)
  •  
2.
  •  
3.
  • Bartha, Erzsebet, et al. (author)
  • Combining functional dependency and ASA III classification for risk stratification-predictors, risk factors, and outcomes following major surgery study (NCT02626546)
  • 2017
  • In: Acta Anaesthesiologica Scandinavica. - : John Wiley & Sons. - 0001-5172 .- 1399-6576. ; 61:8, s. 1011-1011
  • Journal article (other academic/artistic)abstract
    • Background: In elderly reclassification of ASA3 class by functional dependency improved prediction of postoperative mortality. We hypothesized that such a reclassification could improve the risk prediction of adverse outcomes also following high risk surgery.Method: We analyzed data collected by the PROFS study in four Swedish academic hospitals. The inclusion criteria were: adults, ASA≥3, major or xmajor/complex surgery (UK surgical severity coding). ASA 3 patients were reclassified into ASA 3a (functionally independent) and 3b (functionally dependent). The adverse outcomes were postoperative complications (yes/no) screened by Postoperative Morbidity Survey (days 3, 7, 10) and mortality (30-day). Complications graded ≥2 by Clavien-Dindo classification were considered. The predictive value of reclassification was analyzed by logistic regression models.Results: Between 2015 Nov2th and 2016 Feb19th 1089 patients were include; 13 were excluded (violation of inclusion criteria), 3 were lost to follow-up and 1073 were analyzed. ASA 3b (vs ASA 3a) patients had higher risk for mortality and for postoperative complications at days 7 and 10. ASA 4 (vs ASA 3) patients had higher risk of all adverse outcomes (Table 1). When age was added in the regression model ASA 3b patients still had higher risk for postoperative complications at day 10, but the significance disappeared when also urgency was added.Conclusion: The loss of significance by adding urgency in the model might be attributed to the dominance of urgent procedures in ASA3b and ASA4 groups. Reclassification of ASA 3 patients by dependency is recommended, as it may predict adverse outcomes and support clinical judgment.
  •  
4.
  • Bartha, Erzsebet, et al. (author)
  • Performance of prediction models of postoperative mortality in high-risk surgical patients in swedish university hospitals : Predictors, Risk factors and Outcome Following major Surgery study (PROFS study NCT02626546)
  • 2017
  • In: Acta Anaesthesiologica Scandinavica. - : John Wiley & Sons. - 0001-5172 .- 1399-6576. ; 61:8, s. 1056-1057
  • Journal article (other academic/artistic)abstract
    • Background: There are several progn ostic prediction models that estimate the probability of postoperative mortality. The role of these models is to support clinical decisions. Before implementation of a prediction model in routine care, it is necessary to analyze its performance in the target population. Our aim was to analyze the performance of four different prediction models of postoperative mortality in a high-risk surgical population.Methods: Data collected from 2015-11-01 until 2016-02-15 in a prospective consecutive observational study (PROFS study) in four university hospitals was used. The inclusion criteria were adult, ASA classification ≥3, and major/complex upper or lower gastrointestinal, urogenital or orthoped ic surgery (UK surgical severity codingA XA PPP). Four prediction models were evaluated: Surgical Outcome Risk Tool (SORT), Surgical APGAR, P-POSSUM and Surgical Risk Scale (SRS). The outcome measure was 90-day mortality. We evaluated the discrimination of the models by area under receiver operator characteristic curve (AUC ROC) before and after recalibration.Results: In total, 1 089 patients were included. Thirteen patients were excluded due to erroneous inclusion, and another three were lost to follow-up, so data from 1 073 was used in this analysis. The mean age was 73 years, the presence of malignancy was 41%, and 90-day mortality was 13% (n = 140). The SORT model had the best discrimination both before and after recalibration. The P-POSSUM model improved after recalibration. The SRS model overestimated, whereas the APGAR model underestimated, the risk of mortality.Conclusions: The original SORT model is promising and could be incorporated as decision support for high-risk surgical patients.
  •  
5.
  •  
6.
  • Beausang, Angela, et al. (author)
  • "Möjligheten att rädda några av dessa kvinnors liv har inte vägts in"
  • 2014
  • In: Dagens Medicin. - : Dagens Medicin.
  • Journal article (pop. science, debate, etc.)abstract
    • Namnet på Socialstyrelsens vägledning lyder: Hur upptäcka våldsutsatthet? Ja, det kan man verkligen fråga sig efter att ha läst detta föga vägledande dokument, skriver ett stort antal kritiska debattörer.
  •  
7.
  • Bergh, Jonas, et al. (author)
  • Tailored fluorouracil, epirubicin, and cyclophosphamide compared with marrow-supported high-dose chemotherapy as adjuvant treatment for high-risk breast cancer : A randomised trial
  • 2000
  • In: The Lancet. - 0140-6736 .- 1474-547X. ; 356:9239, s. 1384-1391
  • Journal article (peer-reviewed)abstract
    • Background: Chemotherapy drug distribution varies greatly among individual patients. Therefore, we developed an individualised fluorouracil, epirubicin, cyclophosphamide (FEC) regimen to improve outcomes in patients with high-risk early breast cancer. We then did a randomised trial to compare this individually tailored FEC regimen with conventional adjuvant chemotherapy followed by consolidation with high-dose chemotherapy with stem-cell support. Methods: 525 women younger than 60 years of age with high-risk primary breast cancer were randomised after surgery to receive nine cycles of tailored FEC to haematological equitoxicity with granulocyte colony-stimulating factor (G-CSF) support (n=251), or three cycles of FEC at standard doses followed by high-dose chemotherapy with cyclophosphamide, thiotepa, and carboplatin (CTCb), and peripheral-blood stem-cell or bone-marrow support (n=274). Both groups received locoregional radiation therapy and tamoxifen for 5 years. The primary outcome measure was relapse-free survival, and analysis was by intention to treat. Findings: At a median follow-up of 34.3 months, there were 81 breast-cancer relapses in the tailored FEC group versus 113 in the CTCb group (double triangular method p=0.04). 60 deaths occurred in the tailored FEC group and 82 in the CTCb group (log-rank p=0.12). Patients in the CTCb group experienced more grade 3 or 4 acute toxicity compared with the tailored FEC group (p<0.0001). Two treatment-related deaths (0.7%) occurred in the CTCb group. Six patients in the tailored FEC group developed acute myeloid leukaemia and three developed myelodysplastic syndrome. Interpretation: Tailored FEC with G-CSF support resulted in a significantly improved relapse-free survival and fewer grade 3 and 4 toxicities compared with marrow-supported high-dose chemotherapy with CTCb as adjuvant therapy of women with high-risk primary breast cancer.
  •  
8.
  •  
9.
  • Blom, Hans-Olof, et al. (author)
  • Removal of RSE induced damages in silicon
  • 1986
  • In: Journal of Vacuum Science & Technology. A. Vacuum, Surfaces, and Films. - 0734-2101 .- 1520-8559. ; 4:3, s. 752-
  • Journal article (peer-reviewed)
  •  
10.
  • Boström, Pontus, 1982, et al. (author)
  • Hypoxia converts human macrophages into triglyceride-loaded foam cells.
  • 2006
  • In: Arteriosclerosis, thrombosis, and vascular biology. - 1524-4636. ; 26:8, s. 1871-6
  • Journal article (peer-reviewed)abstract
    • OBJECTIVE: Atherosclerotic lesions have regions that are hypoxic. Because the lesion contains macrophages that are loaded with lipid, we investigated whether hypoxia can influence the accumulation of lipids in these cells. METHODS AND RESULTS: Exposure of human macrophages to hypoxia for 24 hours resulted in an increased formation of cytosolic lipid droplets and an increased accumulation of triglycerides. Exposure of the macrophages to oxidized low-density lipoprotein (oxLDL) increased the accumulation of cytosolic lipid droplets because of an increase in cellular cholesterol esters. The accumulation of lipid droplets in oxLDL-treated cells was further increased after hypoxia, caused by an increased level of triglycerides. Expression analyses combined with immunoblot or RT-PCR demonstrated that hypoxia increased the expression of several genes that could promote the accumulation of lipid droplets. Hypoxia increased the mRNA and protein levels of adipocyte differentiation-related protein (ADRP). It is well known that an increased expression of ADRP increases the formation of lipid droplets. Hypoxia decreased the expression of enzymes involved in beta-oxidation (acyl-coenzyme A synthetase and acyl-coenzyme A dehydrogenase) and increased the expression of stearoyl-coenzyme A desaturase, an important enzyme in the fatty acid biosynthesis. Moreover, exposure to hypoxia decreased the rate of beta-oxidation, whereas the accumulation of triglycerides increased. CONCLUSIONS: The results demonstrate that exposure of human macrophages to hypoxia causes an accumulation of triglyceride-containing cytosolic lipid droplets. This indicates that the hypoxia present in atherosclerotic lesions can contribute to the formation of the lipid-loaded macrophages that characterize the lesion and to the accumulation of triglycerides in such lesions.
  •  
Skapa referenser, mejla, bekava och länka
  • Result 1-10 of 49
Type of publication
journal article (38)
conference paper (4)
doctoral thesis (2)
book chapter (2)
editorial collection (1)
reports (1)
show more...
other publication (1)
show less...
Type of content
peer-reviewed (34)
other academic/artistic (10)
pop. science, debate, etc. (5)
Author/Editor
Wiklund, Peter (6)
Olofsson, Sven-Olof, ... (6)
Leimar, Olof (6)
Wiklund, Christer (6)
Wiklund, Olov, 1943 (6)
Nilsson, Lena (5)
show more...
Akre, Olof (5)
Bartha, Erzsebet (5)
Carlsson, Stefan (4)
Steineck, Gunnar, 19 ... (4)
Borén, Jan, 1963 (4)
Wiklund, P (3)
Mattsson Hultén, Lil ... (3)
Haider, Jutta (3)
Rivano Eckerdal, Joh ... (3)
Sundin, Olof (3)
Ahlstrand, Rebecca, ... (3)
Ståhlman, Marcus, 19 ... (3)
Brattström, Olof (3)
Kjellberg, Sara (3)
Norström, H (3)
Petersson, CS (3)
Öhman, Lars-Olof (3)
Olsson, Mats (3)
Blom, Hans-Olof (3)
Gotthard, Karl (2)
Malmström, Per (2)
Bengtsson, Nils-Olof (2)
Wiklund, Johan (2)
Bergh, Jonas (2)
Adding, Christofer (2)
Nyberg, Tommy (2)
CARLSSON, STEFAN, 19 ... (2)
Adiels, Martin, 1976 (2)
Ljungman, Per (2)
Bjartell, Anders (2)
Kellokumpu-Lehtinen, ... (2)
Stranne, Johan, 1970 (2)
Hanell, Fredrik (2)
Carlsson, Hanna (2)
Teneberg, Susann, 19 ... (2)
Flodmark, Olof (2)
Lindman, Henrik (2)
Angenete, Eva, 1972 (2)
Bock, David, 1976 (2)
Haglind, Eva, 1947 (2)
Levin, Malin, 1973 (2)
Lidén, Jan (2)
Lantz, Anna (2)
Uvebrant, Paul, 1951 (2)
show less...
University
University of Gothenburg (11)
Umeå University (9)
Uppsala University (9)
Lund University (7)
Stockholm University (6)
Karolinska Institutet (6)
show more...
Örebro University (4)
Chalmers University of Technology (4)
Linköping University (2)
Jönköping University (2)
Linnaeus University (2)
RISE (2)
Royal Institute of Technology (1)
Luleå University of Technology (1)
University of Borås (1)
VTI - The Swedish National Road and Transport Research Institute (1)
show less...
Language
English (41)
Swedish (7)
Undefined language (1)
Research subject (UKÄ/SCB)
Medical and Health Sciences (14)
Natural sciences (7)
Social Sciences (5)
Engineering and Technology (3)
Humanities (3)

Year

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view